A new clinical study shows the Pfizer drug Lyrica, which is currently approved for other pain uses, can be effectively used for spinal cord pain, according to a release by Pfizer.
Lyrica is currently approved in the United States for diabetic nerve pain, shingles-related discomfort, fibromyalgia and epileptic seizures.
Pfizer said the study involved 220 patients in 10 countries. Preliminary results showed the most common side effects were sleep troubles, dizziness, fatigue, dry mouth and blurred vision.
Read the Pfizer release on Lyrica.
Related Articles on Pain Medications:
New Spine Pain Management-Affiliated Center Opens in Florida
Dr. Otis Brawley Discusses Treatments for Tailbone Pain
Study: Acupuncture Has No Significant Impact on Back Pain, May Produce Negative Outcomes